Clinical meaning
Men's health encompasses a variety of conditions such as benign prostatic hyperplasia (BPH), prostate cancer, and erectile dysfunction (ED), each with distinct cellular and tissue-level changes. For instance, in BPH, hormonal changes, particularly the imbalance between testosterone and estrogen, lead to prostatic tissue hyperplasia. This results in an increase in the number of epithelial and stromal cells, causing obstruction in the urethra. In prostate cancer, genetic mutations contribute to uncontrolled cellular proliferation, leading to malignant growth. ED may result from vascular, neurogenic, or hormonal dysfunction affecting the ability to achieve or maintain an erection, often linked to endothelial dysfunction and reduced nitric oxide availability. Understanding these pathophysiological changes is critical for effective management and treatment.
Diagnosis & workup
Diagnostics & workup: - Monitor prostate-specific antigen (PSA) levels - Assess digital rectal examination (DRE) findings - Expect urinalysis results for urinary obstruction - Evaluate imaging studies such as transrectal ultrasound - Conduct testosterone level testing - Assess for metabolic syndrome indicators - Monitor for comorbidities like cardiovascular disease